home / stock / ctso / ctso quote
Last: | $0.8217 |
---|---|
Change Percent: | 1.02% |
Open: | $0.87 |
Close: | $0.8217 |
High: | $0.87 |
Low: | $0.79 |
Volume: | 180,982 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.8217 | $0.87 | $0.8217 | $0.87 | $0.79 | 180,982 | 04-24-2024 |
$0.879 | $0.82005 | $0.879 | $0.92 | $0.8 | 108,104 | 04-23-2024 |
$0.81 | $0.8421 | $0.81 | $0.8625 | $0.7928 | 97,907 | 04-22-2024 |
$0.802 | $0.82495 | $0.802 | $0.8297 | $0.79 | 46,299 | 04-19-2024 |
$0.801 | $0.81 | $0.801 | $0.85 | $0.7899 | 101,761 | 04-18-2024 |
$0.79 | $0.782 | $0.79 | $0.85 | $0.782 | 38,395 | 04-17-2024 |
$0.7977 | $0.851 | $0.7977 | $0.87 | $0.7977 | 153,722 | 04-16-2024 |
$0.8668 | $0.88 | $0.8668 | $0.94 | $0.8536 | 71,836 | 04-15-2024 |
$0.872 | $0.89 | $0.872 | $0.96 | $0.865 | 75,953 | 04-12-2024 |
$0.9048 | $0.95 | $0.9048 | $0.97535 | $0.9 | 108,903 | 04-11-2024 |
$0.96 | $0.97 | $0.96 | $0.98 | $0.95 | 13,857 | 04-10-2024 |
$0.9799 | $0.98 | $0.9799 | $0.9991 | $0.945 | 48,248 | 04-09-2024 |
$0.9623 | $1 | $0.9623 | $1 | $0.95 | 64,625 | 04-08-2024 |
$1.01 | $0.9307 | $1.01 | $1.02 | $0.9307 | 165,854 | 04-05-2024 |
$0.955 | $0.93 | $0.955 | $0.96 | $0.9 | 56,083 | 04-04-2024 |
$0.9246 | $0.96 | $0.9246 | $0.96 | $0.880362 | 78,360 | 04-03-2024 |
$0.955 | $0.9629 | $0.955 | $0.9629 | $0.8921 | 216,794 | 04-02-2024 |
$0.909 | $0.95 | $0.909 | $0.96 | $0.881 | 114,700 | 04-01-2024 |
$0.95 | $0.91 | $0.95 | $0.96 | $0.8624 | 116,409 | 03-29-2024 |
$0.95 | $0.91 | $0.95 | $0.96 | $0.8624 | 116,409 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
CytoSorbents Corporation Company Name:
CTSO Stock Symbol:
NASDAQ Market:
CytoSorbents Corporation Website:
PRINCETON, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening condit...
PRINCETON, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced ...
STAR-T trial results selected for a Breakout Presentation at the American Association of Thoracic Surgery Annual Meeting in late-April 2024 CytoSorbents intends to submit DrugSorb-ATR for regulatory approval to U.S. Food & Drug Administration (FDA) and Health Canada this year ...